Show simple item record

Efficacy of durvalumab in patients with stage III NSCLC who experience pneumonitis (PACIFIC)

dc.contributor.authorDennis, P. A.
dc.contributor.authorTaboada, M.
dc.contributor.authorWadsworth, C.
dc.contributor.authorAntonia, S. J.
dc.contributor.authorOzguroglu, M.
dc.contributor.authorVansteenkiste, J. F.
dc.contributor.authorNaidoo, J.
dc.contributor.authorFaivre-Finn, C.
dc.contributor.authorVillegas, A.
dc.contributor.authorDaniel, D.
dc.contributor.authorMurakami, S.
dc.contributor.authorHui, R.
dc.contributor.authorLee, K. H.
dc.contributor.authorCho, B. C.
dc.contributor.authorKubota, K.
dc.date.accessioned2021-03-05T13:04:02Z
dc.date.available2021-03-05T13:04:02Z
dc.identifier.citationVansteenkiste J. F. , Naidoo J., Faivre-Finn C., Ozguroglu M., Villegas A., Daniel D., Murakami S., Hui R., Lee K. H. , Cho B. C. , et al., "Efficacy of durvalumab in patients with stage III NSCLC who experience pneumonitis (PACIFIC)", 44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona, İspanya, 27 Eylül - 01 Ekim 2019, cilt.30, ss.592-593
dc.identifier.othervv_1032021
dc.identifier.otherav_b04796dd-a8f3-4558-aeda-7f1737b0b134
dc.identifier.urihttp://hdl.handle.net/20.500.12627/117531
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectOnkoloji
dc.subjectONKOLOJİ
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.titleEfficacy of durvalumab in patients with stage III NSCLC who experience pneumonitis (PACIFIC)
dc.typeBildiri
dc.contributor.departmentKU Leuven , ,
dc.identifier.volume30
dc.contributor.firstauthorID157592


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record